Ralliant Corp
RAL NYSE Industrial Instruments For Measurement, Display, And Control Financials FY2023βFY2025
What Ralliant Corp does
No business description yet.
- Legal name
- Ralliant Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0002041385-26-000023
0002041385
Revenue and margins
Ralliant Corp had $2.1B of revenue in fiscal 2025, down 4.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $358M in fiscal 2025, 17.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ralliant Corp returned $11.3M to shareholders in fiscal 2025, 3% of free cash flow. The diluted share count rose 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Ralliant Corp can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $0.0M | $0.0M | $319M |
| Debt incl. finance leases | β | $0.0M | $1.1B |
| Net debt / EBITDA | β | 0.0x | β |
| Debt / equity | β | 0.0x | 0.7x |
| Interest coverage | β | β | β36.6x |
| Current ratio | β | 1.2x | 0.8x |
| Quick ratio | β | 0.6x | 0.6x |
| Total assets | β | $4.7B | $3.8B |
| Total liabilities | β | $957M | $2.2B |
| Shareholders' equity | $2.3B | $3.8B | $1.6B |
| Net debt (β = net cash) | β | $0.0M | $830M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 3 / 9 |
| Accruals ratio | β | β2.1% | β37.9% |
| Altman Z'' | β | 4.90 | β2.76 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $2.2B | $2.2B | $2.1B |
| Gross profit | $1.1B | $1.1B | $1.0B |
| Research and development | $162M | $164M | $165M |
| Operating income | $512M | $460M | β$1.2B |
| Interest expense | $0.0M | $0.0M | $32.3M |
| Pretax income | $510M | $433M | β$1.2B |
| Income tax | $93.0M | $78.0M | $6.1M |
| Net income | $417M | $355M | β$1.2B |
| Diluted EPS | $3.70 | $3.15 | β$10.84 |
| Diluted shares | 0.11B | 0.11B | 0.11B |
| Cash flow | |||
| Cash from operations | $462M | $455M | $398M |
| Capital expenditure | $29.2M | $34.3M | $39.2M |
| Free cash flow | $433M | $420M | $358M |
| Depreciation and amortization | $30.7M | $113M | $116M |
| Stock-based compensation | $25.0M | $24.5M | $56.2M |
| Acquisitions | $0.0M | $1.7B | $0.0M |
| Dividends paid | $0.0M | $0.0M | $11.3M |
| Dividends and buybacks | $0.0M | $0.0M | $11.3M |
| Balance sheet | |||
| Cash and short-term investments | $0.0M | $0.0M | $319M |
| Total debt | β | $0.0M | $1.1B |
| Current assets | β | $619M | $976M |
| Current liabilities | β | $534M | $1.2B |
| Inventory | β | $283M | $302M |
| Property and equipment, net | β | $200M | $214M |
| Goodwill | $1.9B | $2.9B | $1.7B |
| Intangible assets | β | $810M | $795M |
| Total assets | β | $4.7B | $3.8B |
| Total liabilities | β | $957M | $2.2B |
| Preferred stock | β | $0.0M | $0.0M |
| Shareholders' equity | $2.3B | $3.8B | $1.6B |
| Margins | |||
| Gross margin | 51.9% | 51.6% | 50.3% |
| Operating margin | 23.7% | 21.3% | β57.2% |
| EBITDA margin | 25.2% | 26.6% | β51.6% |
| Net margin | 19.3% | 16.5% | β59.1% |
| FCF margin | 20.1% | 19.5% | 17.3% |
| Returns | |||
| Return on capital | β | 10.0% | β37.9% |
| Return on capital employed | β | 11.0% | β44.4% |
| Return on equity | 18.4% | 11.8% | β45.3% |
| Return on assets | β | 7.5% | β28.6% |
| Return on tangible equity | 103.1% | 2,686.4% | β |
| Growth | |||
| Revenue growth | β | β0.0% | β4.0% |
| Net income growth | β | β14.9% | β444.8% |
| EPS growth | β | β14.9% | β444.1% |
| FCF growth | β | β2.9% | β14.7% |
| Share count change | β | 0.0% | 0.1% |
| Financial health | |||
| Net debt / EBITDA | β | 0.0x | β |
| Debt / equity | β | 0.0x | 0.7x |
| Interest coverage | β | β | β36.6x |
| Current ratio | β | 1.2x | 0.8x |
| Quick ratio | β | 0.6x | 0.6x |
| Capital allocation | |||
| Capex / revenue | 1.4% | 1.6% | 1.9% |
| Stock comp / revenue | 1.2% | 1.1% | 2.7% |
| Payouts / FCF | 0.0% | 0.0% | 3.2% |
| Quality scores | |||
| Piotroski F-score | β | β | 3.0 |
| Altman Z'' | β | 4.9 | β2.8 |
| Accruals ratio | β | β2.1% | β37.9% |
Source: SEC EDGAR XBRL filings (CIK 0002041385). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.